Elotuzumab
Selinexor
Carfilzomib
(UPDATE) Ixazomib
The Leukemia and Lymphoma Society
National Cancer Institute (NCI) - Supported Cancer Clinical Trials
NCCN COVID-19 Resources Page
ASH: COVID-19 Resources for Managing Blood Cancers